Notice of Availability of Government-Owned Inventions; Available for Licensing, 69144 [05-22516]
Download as PDF
<![CDATA[
69144
Federal Register / Vol. 70, No. 218 / Monday, November 14, 2005 / Notices
• E-mail: Susan.Brown@uspto.gov.
Include ‘‘0651–0045 copy request’’ in
the subject line of the message.
• Fax: 571–273–0112, marked to the
attention of Susan Brown.
• Mail: Susan K. Brown, Records
Officer, Office of the Chief Information
Officer, Office of Data Architecture and
Services, Data Administration Division,
U.S. Patent and Trademark Office, PO
Box 1450, Alexandria, VA 22313–1450.
Written comments and
recommendations for the proposed
information collection should be sent on
or before December 14, 2005 to David
Rostker, OMB Desk Officer, Room
10202, New Executive Office Building,
725 17th Street NW., Washington, DC
20503.
Dated: November 7, 2005.
Susan K. Brown,
Records Officer, USPTO, Office of the Chief
Information Officer,Office of Data
Architecture and Services, Data
Administration Division.
[FR Doc. 05–22529 Filed 11–10–05; 8:45 am]
BILLING CODE 3510–16–P
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Availability of GovernmentOwned Inventions; Available for
Licensing
Department of the Navy, DOD.
Notice.
AGENCY:
ACTION:
SUMMARY: The Department of the Navy
hereby gives notice of the availability of
exclusive or partially exclusive licenses
to practice worldwide under the
following pending patents. Any license
granted shall comply with 35 U.S.C. 209
and 37 CFR Part 404. Applications will
be evaluated utilizing the following
criteria: (1) Ability to manufacture and
market the technology; (2)
manufacturing and marketing ability; (3)
time required to bring technology to
market and production rate; (4)
royalties; (5) technical capabilities; and
(6) small business status.
Patent application Serial Number 60/
642,771 entitled ‘‘Fimbrial Adhesin as
Vaccine Against Escherichia Coli’’ filed
on January 11, 2005. The present
invention relates to the field of inducing
an immune response against
diarrheagenic bacteria including
enterotoxigenic Escherichia coli using
bacterial fimbriae components.
Patent application Serial Number 60/
668,591 entitled ‘‘Recombinant
Antigens for the Detection of Coxiella
Burnetii’’ filed on April 6, 2005. The
present invention relates to Coxiella
VerDate Aug<31>2005
17:16 Nov 10, 2005
Jkt 208001
burnetii peptide antigens and
recombinant DNA encoding the
peptides.
Patent application Serial Number 10/
934,686, entitled ‘‘Hospital and Clinic
Emergency Preparedness Optimization
System’’ filed on September 3, 2004.
The present invention relates to hospital
and ambulatory clinic emergency
management systems.
Patent application Serial Number 60/
683,787 entitled ‘‘Anti-Adhesin Based
Passive Immunoprophylactic’’ filed on
May 24, 2005. The present invention
relates to a pharmaceutical useful in
conferring passive protection against
diarrhea caused by enterotoxigenic
Esherichia coli.
Patent application Serial Number 60/
709,804 entitled ‘‘A Method for the
Evaluation of Dengue Virus Therapeutic
Agents’’ filed on August 22, 2005. The
present invention relates to a method for
evaluating the immunogenicity and
efficacy of vaccine or drug formulations
against dengue virus using a pig or
porcine cells as models of infection and
pathogenicity.
Patent application Serial Number 60/
715,578 entitled ‘‘Potts Reagent
Alcohol-Solvent Extraction System’’
filed on September 12, 2005. This
invention relates to a method for
decontaminating alcohol so that it may
be recycled in histology and other
laboratory settings.
Patent application serial Number, 60/
722,086, entitled ‘‘Immunogenic
Capsule Composition for Use as a
Vaccine Against Campylobacter Jejuni’’
filed September 21, 2005. This
invention relates to a pharmaceutical
useful in conferring protection against
diarrhea caused by Campylobacter
jejuni and a method of administering
said pharmaceutical.
Patent application Serial Number 60/
627,811 entitled ‘‘Diagnostic Assay for
Rickettsial prowazekii Disease By
Detection of Responsive Gene
Expression’’ filed on November 10,
2004. The present invention relates to a
method of diagnosing epidemic typhus
caused by the bacteria Rickettsia
prowazekii by analysis of modulation of
host gene expression. The method
contemplates the use of micro-array
technology for the detection and
analysis of gene up or down regulation
in response to bacterial infection.
DATES: Applications for an exclusive or
partially exclusive license may be
submitted at any time from the date of
this notice.
ADDRESSES: Submit application to the
Office of Technology Transfer, Naval
Medical Research Center, 503 Robert
Grant Ave., Silver Spring, MD 20910–
7500.
PO 00000
Frm 00012
Fmt 4703
Sfmt 4703
Dr.
Charles Schlagel, Director, Office of
Technology Transfer, Naval Medical
Research Center, 503 Robert Grant Ave.,
Silver Spring, MD 20910–7500,
telephone 301–319–7428 or e-mail at:
schlagelc@nmrc.navy.mil.
FOR FURTHER INFORMATION CONTACT:
Dated: October 31, 2005.
I.C. Le Moyne Jr.,
Lieutenant Commander, Judge Advocate
General’s Corps, U.S. Navy, Alternate Federal
Register Liaison Officer.
[FR Doc. 05–22516 Filed 11–10–05; 8:45 am]
BILLING CODE 3810–FF–P
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Performance Review Board
Membership
Department of the Navy, DOD.
Notice.
AGENCY:
ACTION:
SUMMARY: Pursuant to 5 U.S.C.
4314(c)(4), the Department of the Navy
(DON) announces the appointment of
members to the DON’s numerous Senior
Executive Service (SES) Performance
Review Boards (PRBs). The purpose of
the PRBs is to provide fair and impartial
review of the annual SES performance
appraisal prepared by the senior
executive’s assigned rating officials; to
make recommendations to authorizing
officials regarding acceptance or
modification of the performance rating;
and to make recommendations for
performance bonuses and basic pay
increases. Composition of the specific
PRBs will be determined on an ad hoc
basis from among individuals listed
below:
ACKLEY, V. MR.
ADAMS, P. MS.
ALLES, R. BGEN
BACHMANN, M. RDML
BARBER III, A. MR.
BARNUM, H. MR.
BELAND, R. DR.
BETRO, T. MR.
BLAIR, A. MS.
BONWICH, S. MR.
BRANT, D. MR.
BRENNAN, A. MS.
BROTHERTON, A. MS.
BURNS, J. RADM
CALI, R. MR.
CIESLAK, R. MR.
COCKHRANE, E. MR.
COOK, C. MR.
COX, A. MR.
CRABTREE, T. MR.
CREEDON, C. MR.
CWALINA, B. MR.
DECKER, J. MS.
DECKER, M. MR.
E:\FR\FM\14NON1.SGM
14NON1
]]>Agencies
[Federal Register Volume 70, Number 218 (Monday, November 14, 2005)]
[Notices]
[Page 69144]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-22516]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Navy
Notice of Availability of Government-Owned Inventions; Available
for Licensing
AGENCY: Department of the Navy, DOD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of the Navy hereby gives notice of the
availability of exclusive or partially exclusive licenses to practice
worldwide under the following pending patents. Any license granted
shall comply with 35 U.S.C. 209 and 37 CFR Part 404. Applications will
be evaluated utilizing the following criteria: (1) Ability to
manufacture and market the technology; (2) manufacturing and marketing
ability; (3) time required to bring technology to market and production
rate; (4) royalties; (5) technical capabilities; and (6) small business
status.
Patent application Serial Number 60/642,771 entitled ``Fimbrial
Adhesin as Vaccine Against Escherichia Coli'' filed on January 11,
2005. The present invention relates to the field of inducing an immune
response against diarrheagenic bacteria including enterotoxigenic
Escherichia coli using bacterial fimbriae components.
Patent application Serial Number 60/668,591 entitled ``Recombinant
Antigens for the Detection of Coxiella Burnetii'' filed on April 6,
2005. The present invention relates to Coxiella burnetii peptide
antigens and recombinant DNA encoding the peptides.
Patent application Serial Number 10/934,686, entitled ``Hospital
and Clinic Emergency Preparedness Optimization System'' filed on
September 3, 2004. The present invention relates to hospital and
ambulatory clinic emergency management systems.
Patent application Serial Number 60/683,787 entitled ``Anti-Adhesin
Based Passive Immunoprophylactic'' filed on May 24, 2005. The present
invention relates to a pharmaceutical useful in conferring passive
protection against diarrhea caused by enterotoxigenic Esherichia coli.
Patent application Serial Number 60/709,804 entitled ``A Method for
the Evaluation of Dengue Virus Therapeutic Agents'' filed on August 22,
2005. The present invention relates to a method for evaluating the
immunogenicity and efficacy of vaccine or drug formulations against
dengue virus using a pig or porcine cells as models of infection and
pathogenicity.
Patent application Serial Number 60/715,578 entitled ``Potts
Reagent Alcohol-Solvent Extraction System'' filed on September 12,
2005. This invention relates to a method for decontaminating alcohol so
that it may be recycled in histology and other laboratory settings.
Patent application serial Number, 60/722,086, entitled
``Immunogenic Capsule Composition for Use as a Vaccine Against
Campylobacter Jejuni'' filed September 21, 2005. This invention relates
to a pharmaceutical useful in conferring protection against diarrhea
caused by Campylobacter jejuni and a method of administering said
pharmaceutical.
Patent application Serial Number 60/627,811 entitled ``Diagnostic
Assay for Rickettsial prowazekii Disease By Detection of Responsive
Gene Expression'' filed on November 10, 2004. The present invention
relates to a method of diagnosing epidemic typhus caused by the
bacteria Rickettsia prowazekii by analysis of modulation of host gene
expression. The method contemplates the use of micro-array technology
for the detection and analysis of gene up or down regulation in
response to bacterial infection.
DATES: Applications for an exclusive or partially exclusive license may
be submitted at any time from the date of this notice.
ADDRESSES: Submit application to the Office of Technology Transfer,
Naval Medical Research Center, 503 Robert Grant Ave., Silver Spring, MD
20910-7500.
FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant
Ave., Silver Spring, MD 20910-7500, telephone 301-319-7428 or e-mail
at: schlagelc@nmrc.navy.mil.
Dated: October 31, 2005.
I.C. Le Moyne Jr.,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy,
Alternate Federal Register Liaison Officer.
[FR Doc. 05-22516 Filed 11-10-05; 8:45 am]
BILLING CODE 3810-FF-P
